​

Zimmer Biomet (ZBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZBH Stock Forecast

Zimmer Biomet (ZBH) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $107.82, with a high of $130.00 and a low of $89.00. This represents a 16.45% increase from the last price of $92.59.

$85 $95 $105 $115 $125 $135 High: $130 Avg: $107.82 Low: $89 Last Closed Price: $92.59

ZBH Stock Rating

Zimmer Biomet stock's rating consensus is Hold, based on 41 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (43.90%), 20 Hold (48.78%), 3 Sell (7.32%), and 0 Strong Sell (0.00%).

Hold
Total 41 3 20 18 0 Strong Sell Sell Hold Buy Strong Buy

ZBH Price Target Upside V Benchmarks

TypeNameUpside
StockZimmer Biomet16.45%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.16%

Price Target Trends

1M3M12M
# Anlaysts-719
Avg Price Target-$98.14$106.16
Last Closing Price$92.59$92.59$92.59
Upside/Downside-5.99%14.66%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2636172129
Feb, 2627162128
Jan, 2644181128
Dec, 2546171129
Nov, 2556151128
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 12, 2026Matt MiksicBarclays$100.00$96.693.42%8.00%
Feb 11, 2026UBS$89.00$93.69-5.01%-3.88%
Jan 28, 2026UBS$86.00$85.270.86%-7.12%
Jan 09, 2026Bernstein$99.00$94.085.23%6.92%
Jan 09, 2026David RomanGoldman Sachs$93.00$94.08-1.15%0.44%
Jan 05, 2026Evercore ISI$120.00$90.0233.30%29.60%
Dec 16, 2025Jeff JohnsonRobert W. Baird$100.00$92.528.08%8.00%
Nov 05, 2025Rick WiseStifel Nicolaus$110.00$87.9125.13%18.80%
Nov 05, 2025Johnson Rice$112.00$88.0527.20%20.96%
Nov 05, 2025Barclays$105.00$103.181.76%13.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 20, 2026William BlairBuyMarket Performinitialise
Feb 12, 2026BarclaysUnderweightUnderweighthold
Feb 11, 2026UBSSellSellhold
Feb 11, 2026CitigroupBuyBuyhold
Jan 26, 2026Cowen & Co.HoldBuyupgrade
Jan 09, 2026BernsteinMarket PerformMarket Performhold
Jan 09, 2026Goldman SachsBuySelldowngrade
Jan 06, 2026Raymond JamesUnderperformMarket Performdowngrade
Jan 05, 2026Evercore ISIPositiveOutperformupgrade
Oct 13, 2025BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.93$1.10$4.91$4.45$3.56---
Avg Forecast$7.17$6.84$7.51$7.98$8.56$9.24$9.99$10.61
High Forecast$7.28$6.90$7.57$8.01$8.82$11.87$10.76$10.73
Low Forecast$7.08$6.75$7.23$7.94$8.44$7.18$9.22$10.43
Surprise %-73.08%-83.92%-34.62%-44.24%-58.41%---

Revenue Forecast

$7B $7B $8B $8B $9B $10B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.83B$6.94B$7.39B$7.68B$8.23B---
Avg Forecast$7.86B$6.87B$7.38B$7.67B$8.01B$8.38B$8.78B$9.19B
High Forecast$7.95B$6.92B$7.43B$7.68B$8.08B$8.38B$8.81B$9.27B
Low Forecast$7.79B$6.80B$7.24B$7.66B$7.92B$8.37B$8.76B$9.07B
Surprise %-13.16%0.95%0.16%0.11%2.76%---

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$401.60M$231.40M$1.02B$903.80M$705.20M---
Avg Forecast$368.25M$224.98M$1.02B$1.67B$1.81B$2.00B$2.10B$2.22B
High Forecast$475.67M$307.13M$1.40B$1.68B$1.85B$2.49B$2.26B$2.25B
Low Forecast$260.83M$142.84M$651.48M$1.67B$1.77B$1.50B$1.93B$2.19B
Surprise %9.06%2.85%--45.98%-61.04%---

ZBH Forecast FAQ

Is Zimmer Biomet stock a buy?

Zimmer Biomet stock has a consensus rating of Hold, based on 41 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 20 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Zimmer Biomet is a neutral investment for most analysts.

What is Zimmer Biomet's price target?

Zimmer Biomet's price target, set by 41 Wall Street analysts, averages $107.82 over the next 12 months. The price target range spans from $89 at the low end to $130 at the high end, suggesting a potential 16.45% change from the previous closing price of $92.59.

How does Zimmer Biomet stock forecast compare to its benchmarks?

Zimmer Biomet's stock forecast shows a 16.45% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (31.16%).

What is the breakdown of analyst ratings for Zimmer Biomet over the past three months?

  • March 2026: 10.34% Strong Buy, 20.69% Buy, 58.62% Hold, 6.90% Sell, 3.45% Strong Sell.
  • February 2026: 7.14% Strong Buy, 25.00% Buy, 57.14% Hold, 7.14% Sell, 3.57% Strong Sell.
  • January 2026: 14.29% Strong Buy, 14.29% Buy, 64.29% Hold, 3.57% Sell, 3.57% Strong Sell.

What is Zimmer Biomet’s EPS forecast?

Zimmer Biomet's average annual EPS forecast for its fiscal year ending in December 2026 is $9.24, marking a 159.55% increase from the reported $3.56 in 2025. Estimates for the following years are $9.99 in 2027, and $10.61 in 2028.

What is Zimmer Biomet’s revenue forecast?

Zimmer Biomet's average annual revenue forecast for its fiscal year ending in December 2026 is $8.38B, reflecting a 1.78% increase from the reported $8.23B in 2025. The forecast for 2027 is $8.78B, and $9.19B for 2028.

What is Zimmer Biomet’s net income forecast?

Zimmer Biomet's net income forecast for the fiscal year ending in December 2026 stands at $2B, representing an 183.23% increase from the reported $705.2M in 2025. Projections indicate $2.1B in 2027, and $2.22B in 2028.